Cargando…
Vonoprazan‐associated long QT syndrome
To our knowledge, this is the first report describing a case of vonoprazan‐associated QT prolongation newly occurring after initiation of the drug and improving after its discontinuation in a patient concurrently receiving polypharmacy including a drug metabolized by CYP3A4.[Image: see text]
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721332/ https://www.ncbi.nlm.nih.gov/pubmed/35004113 http://dx.doi.org/10.1002/jgf2.485 |